Page last updated: 2024-11-04

sb 202190 and Subarachnoid Hemorrhage

sb 202190 has been researched along with Subarachnoid Hemorrhage in 1 studies

4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole: structure given in first source; inhibits p38 MAP kinase

Subarachnoid Hemorrhage: Bleeding into the intracranial or spinal SUBARACHNOID SPACE, most resulting from INTRACRANIAL ANEURYSM rupture. It can occur after traumatic injuries (SUBARACHNOID HEMORRHAGE, TRAUMATIC). Clinical features include HEADACHE; NAUSEA; VOMITING, nuchal rigidity, variable neurological deficits and reduced mental status.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Li, P1
Li, X1
Deng, P1
Wang, D1
Bai, X1
Li, Y1
Luo, C1
Belguise, K1
Wang, X1
Wei, X1
Xia, Z1
Yi, B1

Other Studies

1 other study available for sb 202190 and Subarachnoid Hemorrhage

ArticleYear
Activation of adenosine A3 receptor reduces early brain injury by alleviating neuroinflammation after subarachnoid hemorrhage in elderly rats.
    Aging, 2020, 11-30, Volume: 13, Issue:1

    Topics: Adenosine A3 Receptor Agonists; Adenosine A3 Receptor Antagonists; Animals; Brain; Brain Injuries; C

2020